Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for systemic lupus erythematosus disease activity
IRCT20181030041500N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of acetylcysteine in systemic lupus erythematosus (SLE) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Lupus disease activity. Started May 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on IRCT20181030041500N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181030041500N2.